TY - JOUR
T1 - Status Epilepticus Protocol Variation Across Accredited National Association of Epilepsy Centers Members
AU - Lamberta, Laura K.
AU - Asmar, Melissa
AU - Fredwall, Megan M.
AU - Ahrens, Stephanie M.
AU - Bai, Shasha
AU - Eisner, Mariah
AU - Lado, Fred Alexander
AU - Schuele, Stephan U.
AU - Clarke, Dave F.
AU - Abdelmoity, Ahmed T.
AU - Davis, Kathryn A.
AU - Hopp, Jennifer L.
AU - Koubeissi, Mohamad Z.
AU - Bensalem Owen, Meriem K.
AU - Herman, Susan T.
AU - Ostendorf, Adam P.
N1 - Publisher Copyright:
Copyright © 2025 The Author(s).
PY - 2025/5/16
Y1 - 2025/5/16
N2 - Objectives Status epilepticus (SE) is a neurologic emergency that requires urgent recognition and medical management. SE management remains heterogeneous across centers. Methods We analyzed SE treatment protocols from level 3 and level 4 epilepsy centers. Discrete data including stabilization measures, timing of treatment phases, medications, doses, and routes of administration were collected from each protocol and described using frequency for categorical variables and median for continuous variables. The distribution of treatment times and dosing were compared with the AES guideline. Results A total of 256 SE treatment protocols were included. Only 66% of SE protocols detailed treatment times. Doses below recommendations occurred in 4% of protocols for initial benzodiazepine (BZD) and 14% for first non-BZD medications. Infusion therapy was outlined in 61% of protocols. Discussion Despite the importance of timeliness in SE management, one third of institutional protocols did not specify treatment times. This analysis of US hospital inpatient SE protocols provides expert opinion regarding infusion therapy management and highlights gaps and targets for improvement in SE treatment.
AB - Objectives Status epilepticus (SE) is a neurologic emergency that requires urgent recognition and medical management. SE management remains heterogeneous across centers. Methods We analyzed SE treatment protocols from level 3 and level 4 epilepsy centers. Discrete data including stabilization measures, timing of treatment phases, medications, doses, and routes of administration were collected from each protocol and described using frequency for categorical variables and median for continuous variables. The distribution of treatment times and dosing were compared with the AES guideline. Results A total of 256 SE treatment protocols were included. Only 66% of SE protocols detailed treatment times. Doses below recommendations occurred in 4% of protocols for initial benzodiazepine (BZD) and 14% for first non-BZD medications. Infusion therapy was outlined in 61% of protocols. Discussion Despite the importance of timeliness in SE management, one third of institutional protocols did not specify treatment times. This analysis of US hospital inpatient SE protocols provides expert opinion regarding infusion therapy management and highlights gaps and targets for improvement in SE treatment.
UR - http://www.scopus.com/inward/record.url?scp=105005659222&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=105005659222&partnerID=8YFLogxK
U2 - 10.1212/WNL.0000000000213689
DO - 10.1212/WNL.0000000000213689
M3 - Article
C2 - 40378375
AN - SCOPUS:105005659222
SN - 0028-3878
VL - 104
JO - Neurology
JF - Neurology
IS - 11
M1 - e213689
ER -